Atara Biotherapeutics Inc (NASDAQ:ATRA)

14.61
Delayed Data
As of 4:03pm ET
 +0.62 / +4.43%
Today’s Change
11.81
Today|||52-Week Range
21.85
-7.30%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization48.0K383.0K956.0K3.8M
 
 
 
 
 
 
Operating ExpensesGross Income-48.0K-383.0K-956.0K-3.8M
 
 
 
 
 
General Expenses58.4M80.9M120.6M233.3M
 
 
 
 
 
Research And Development41.6M56.5M81.2M167.5M
 
 
 
 
 
Total Operating Expenses58.4M81.2M121.5M237.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-58.4M-81.2M-121.5M-237.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-57.2M-79.0M-119.5M-230.7M
 
 
 
 
 
Income Taxes-9.0K-10.0K-14.0K-44.0K
 
 
 
 
 
Net Income-57.2M-79.0M-119.5M-230.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS25.6M28.7M29.9M43.8M
 
 
 
 
 
Shares To Calculate EPS Diluted25.6M28.7M29.9M43.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.24-$2.75-$4.00-$5.27
 
 
 
 
 
EPS Diluted-$2.24-$2.75-$4.00-$5.27